QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE) — FDA Approval NDA207921 (NORTON WATERFORD)
QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE) — FDA Approval NDA207921 (NORTON WATERFORD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: QVAR REDIHALER; Active ingredients: BECLOMETHASONE DIPROPIONATE; Application number: NDA207921.
| Brand name | QVAR REDIHALER |
|---|---|
| Active ingredients | BECLOMETHASONE DIPROPIONATE |
| Application number | NDA207921 |
| Sponsor | NORTON WATERFORD |
| Dosage form | AEROSOL, METERED |
| Route | INHALATION |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20170803 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →